Publications by authors named "Arpan Jain"
Article Synopsis
- * In a trial with 140 participants, those receiving LOLA, along with lactulose and rifaximin, showed significantly better improvement in OHE grades, faster recovery times, and lower mortality rates compared to those receiving a placebo.
- * The results indicate that LOLA, when combined with standard treatments, leads to greater reductions in ammonia and inflammatory markers, demonstrating its potential benefits in managing severe OHE.
